WhatsApp
backNews Article

Jubilant Pharmova Receives Shareholder Approval for Private Placement of Non-Convertible Debentures

Special Resolution passed unanimously by shareholders on November 20, 2026, enabling company to raise funds via debentures

Jubilant Pharmova Limited shareholders have approved the issuance of Non-Convertible Debentures via private placement after a postal ballot vote held on November 20, 2026, enabling the company to raise capital through debt instruments.

12 hours ago|JUBLPHARMA+0.00%
Jubilant Pharmova LimitedJUBLPHARMAPreferential Issue

Jubilant Pharmova Limited

Preferential Issue

Jubilant Pharmova Limited has obtained shareholder approval through a postal ballot conducted on November 20, 2026, for the issuance of Non-Convertible Debentures on a private placement basis, allowing the company to raise debt capital.

The resolution for the issuance of Non-Convertible Debentures was passed with an overwhelming majority, with 99.3895% of votes cast in favor.

The postal ballot voting included e-voting by promoters, institutional shareholders, and public non-institutions, with a total of 126,660,315 votes polled against a total of 159,281,139 shares outstanding.

The company facilitated remote e-voting from October 22, 2026, to November 20, 2026, with the results publicly disclosed and available on Jubilant Pharmova's and NSDL's websites.

The approval empowers Jubilant Pharmova to proceed with the issuance of debt securities privately placed, supporting its fundraising plans.

Highlights

  • Special Resolution approved on November 20, 2026.
  • Total votes polled: 126,660,315 (79.52% of shares).
  • Votes in favor: 125,887,158 (99.39%).
  • Votes against: 773,157 (0.61%).
  • Promoters and Promoter Group voted 100% in favor with 75,938,622 votes.
  • Public Institutions voted 98.09% in favor on 40,426,055 votes cast.

Key Data Snapshot

Date of Postal Ballot20-11-2026
Total shareholders on cut-off date (October 9, 2026)84112
Total shares outstanding159,281,139
Total votes polled126,660,315
Percentage of shares voted79.52%
Votes in favor125,887,158
Votes against773,157
Promoter votes polled75,938,622
Public Institutions votes polled40,426,055
Public Non-Institutions votes polled10,295,638

What happened

  • Jubilant Pharmova Limited held a postal ballot concluding on November 20, 2026, seeking shareholder approval for issuing Non-Convertible Debentures on a private placement basis.
  • The special resolution was passed with the requisite majority based on votes cast electronically by shareholders.

Key details

  • Voting was conducted via remote e-voting from October 22 to November 20, 2026.
  • Total votes polled represented approximately 79.52% of the company's outstanding shares.
  • Promoter and promoter group voted 100% in favor of the resolution.
  • Public institutional shareholders voted 98.09% in favor.
  • Public non-institutional shareholders voted 99.99% in favor.
  • No postal ballot paper voting other than e-voting was reported due to regulatory provisions.

Regulatory and governance context

  • The postal ballot process complied with the Companies Act, 2013, SEBI Listing Regulations, and related circulars.
  • The scrutinizer report certified the fairness and transparency of the voting process.
  • The resolution falls under the category of fundraising via debt instruments approved by shareholders as required for private placements.

More News on Preferential Issue

View all

Latest corporate announcements and market updates in Preferential Issue.

View all news
Jubilant Pharmova Receives Shareholder Approval for…